Interviewers ask this kind of question to surface how you think, not what you remember. The strongest answers are specific, calmly told, and end on what changed.
Create an account or sign in to see model answers and concept guides, and to track the questions you’ve practiced.
During batch release, one of three sterility test replicates comes back with turbidity that could be growth or could be a media artifact. QC wants to invalidate and retest; the clinical supply is on a tight timeline for a Phase I dose. When does this stop being your call?
Voice isn’t supported in this browser. Type your answer in the box.
Create a free account to get more critiques.